BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34370015)

  • 1. A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice.
    Perry RA; Craig SL; Gault VA; Flatt PR; Irwin N
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34370015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Peptides; 2018 Feb; 100():202-211. PubMed ID: 29412820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice.
    Hasib A; Khan D; Craig SL; Gault VA; Flatt PR; Irwin N
    Eur J Pharmacol; 2019 Dec; 865():172733. PubMed ID: 31614140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice.
    Craig SL; Perry RA; Vyavahare SS; Ng MT; Gault VA; Flatt PR; Irwin N
    Biochem Pharmacol; 2020 Jan; 171():113723. PubMed ID: 31756326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice.
    Hasib A; Ng MT; Gault VA; Khan D; Parthsarathy V; Flatt PR; Irwin N
    Diabetologia; 2017 Mar; 60(3):541-552. PubMed ID: 28004148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Eur J Pharmacol; 2018 Sep; 834():126-135. PubMed ID: 30025814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
    Irwin N; Hunter K; Montgomery IA; Flatt PR
    Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential.
    Pathak NM; Pathak V; Gault VA; McClean S; Irwin N; Flatt PR
    Biochem Pharmacol; 2018 Sep; 155():264-274. PubMed ID: 30028989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ψ-Xenin-6 enhances sitagliptin effectiveness, but does not improve glucose tolerance.
    Craig SL; Gault VA; Hamscher G; Irwin N
    J Endocrinol; 2020 May; 245(2):219-230. PubMed ID: 32130206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.
    Tanday N; English A; Lafferty RA; Flatt PR; Irwin N
    Front Endocrinol (Lausanne); 2021; 12():674704. PubMed ID: 34054734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin.
    Martin CM; Parthsarathy V; Hasib A; Ng MT; McClean S; Flatt PR; Gault VA; Irwin N
    PLoS One; 2016; 11(3):e0152818. PubMed ID: 27032106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
    Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of independent and combined effects of the neurotensin receptor agonist, JMV-449, and incretin mimetics on pancreatic islet function, glucose homeostasis and appetite control.
    Craig SL; Gault VA; Shiels CE; Hamscher G; Irwin N
    Biochim Biophys Acta Gen Subj; 2021 Aug; 1865(8):129917. PubMed ID: 33964357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel chemically modified analogue of xenin-25 exhibits improved glucose-lowering and insulin-releasing properties.
    Parthsarathy V; Irwin N; Hasib A; Martin CM; McClean S; Bhat VK; Ng MT; Flatt PR; Gault VA
    Biochim Biophys Acta; 2016 Apr; 1860(4):757-64. PubMed ID: 26802310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4(Lys
    Hasib A; Ng MT; Tanday N; Craig SL; Gault VA; Flatt PR; Irwin N
    Diabetes Metab Res Rev; 2019 Mar; 35(3):e3106. PubMed ID: 30499633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the biological activity of xenin-25 degradation fragment peptides.
    Martin CM; Parthsarathy V; Pathak V; Gault VA; Flatt PR; Irwin N
    J Endocrinol; 2014 May; 221(2):193-200. PubMed ID: 24520141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally produced xenin and the neurotensinergic system in pancreatic islet function and β-cell survival.
    Khan D; Vasu S; Moffett RC; Gault VA; Flatt PR; Irwin N
    Biol Chem; 2017 Dec; 399(1):79-92. PubMed ID: 28822218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitagliptin in mice by upregulating xenin.
    Craig SL; Gault VA; Flatt PR; Irwin N
    Biochem Pharmacol; 2021 Jan; 183():114355. PubMed ID: 33279496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an enzymatically stable C-terminal hexapseudopeptide fragment peptide of xenin-25, ψ-xenin-6, on pancreatic islet function and metabolism.
    Craig SL; Gault VA; McClean S; Hamscher G; Irwin N
    Mol Cell Endocrinol; 2019 Oct; 496():110523. PubMed ID: 31352038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice.
    Pathak NM; Millar PJB; Pathak V; Flatt PR; Gault VA
    Mol Cell Endocrinol; 2018 Jan; 460():200-208. PubMed ID: 28754350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.